140 related articles for article (PubMed ID: 37846711)
1. [Effect of Human Bone Marrow Mesenchymal Stem Cells with Ectopic High OCT4 Expression on T Lymphocyte Function].
Guo XP; Chen YF; Chen P; Pan J; Ying PT; Zhao N; Tang YM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1523-1530. PubMed ID: 37846711
[TBL] [Abstract][Full Text] [Related]
2. [Interleukin-12 restores and promotes the T-cell immune function inhibited by 5-fluorouracil].
Chi PD; Li L; Fan YY; Wu CY
Ai Zheng; 2007 Aug; 26(8):801-8. PubMed ID: 17697537
[TBL] [Abstract][Full Text] [Related]
3. Effect of human bone marrow mesenchymal stromal cells on cytokine production by peripheral blood naive, memory, and effector T cells.
Laranjeira P; Pedrosa M; Pedreiro S; Gomes J; Martinho A; Antunes B; Ribeiro T; Santos F; Trindade H; Paiva A
Stem Cell Res Ther; 2015 Jan; 6(1):3. PubMed ID: 25559824
[TBL] [Abstract][Full Text] [Related]
4. Reduced regulatory effects of bone marrow-derived mesenchymal stem cells on activated T lymphocytes and Th1/Th2 cytokine secretion in children with aplastic anemia.
Guo X; Weng W; Wang Y; Pan J; Li S; Chen Y; Song H; Zhang J; Xu W; Xu X; Tang Y
Clin Exp Med; 2023 Dec; 23(8):4633-4646. PubMed ID: 37930604
[TBL] [Abstract][Full Text] [Related]
5. Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells.
Guo Z; Zheng C; Chen Z; Gu D; Du W; Ge J; Han Z; Yang R
Eur J Immunol; 2009 Oct; 39(10):2840-9. PubMed ID: 19637224
[TBL] [Abstract][Full Text] [Related]
6. Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-γ and tumor necrosis factor-α stimulation.
Cuerquis J; Romieu-Mourez R; François M; Routy JP; Young YK; Zhao J; Eliopoulos N
Cytotherapy; 2014 Feb; 16(2):191-202. PubMed ID: 24438900
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory effect of human bone marrow-derived mesenchymal stromal/stem cells on peripheral blood T cells from rheumatoid arthritis patients.
Pedrosa M; Gomes J; Laranjeira P; Duarte C; Pedreiro S; Antunes B; Ribeiro T; Santos F; Martinho A; Fardilha M; Domingues MR; Abecasis M; P da Silva JA; Paiva A
J Tissue Eng Regen Med; 2020 Jan; 14(1):16-28. PubMed ID: 31502378
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cells control alloreactive CD8(+) CD28(-) T cells.
Engela AU; Baan CC; Litjens NH; Franquesa M; Betjes MG; Weimar W; Hoogduijn MJ
Clin Exp Immunol; 2013 Dec; 174(3):449-58. PubMed ID: 24028656
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
[TBL] [Abstract][Full Text] [Related]
11. Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction.
Prevosto C; Zancolli M; Canevali P; Zocchi MR; Poggi A
Haematologica; 2007 Jul; 92(7):881-8. PubMed ID: 17606437
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells.
Ribeiro A; Laranjeira P; Mendes S; Velada I; Leite C; Andrade P; Santos F; Henriques A; Grãos M; Cardoso CM; Martinho A; Pais M; da Silva CL; Cabral J; Trindade H; Paiva A
Stem Cell Res Ther; 2013 Oct; 4(5):125. PubMed ID: 24406104
[TBL] [Abstract][Full Text] [Related]
13. [Regulation of immunological balance between TH1/TH2 and Tc1/Tc2 lymphocytes by prostaglandin E2].
Bao YS; Wang M; Zhang P; Zhou Z; Zhai WJ; Wang H; Jiang EL; Huang Y; Feng SZ; Han MZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):431-5. PubMed ID: 20416182
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells.
Luz-Crawford P; Kurte M; Bravo-Alegría J; Contreras R; Nova-Lamperti E; Tejedor G; Noël D; Jorgensen C; Figueroa F; Djouad F; Carrión F
Stem Cell Res Ther; 2013 Jun; 4(3):65. PubMed ID: 23734780
[TBL] [Abstract][Full Text] [Related]
15. Interferon-γ enhances the immunosuppressive ability of canine bone marrow-derived mesenchymal stem cells by activating the TLR3-dependent IDO/kynurenine pathway.
Deng J; Li D; Huang X; Li W; Zhao F; Gu C; Shen L; Cao S; Ren Z; Zuo Z; Deng J; Yu S
Mol Biol Rep; 2022 Sep; 49(9):8337-8347. PubMed ID: 35690960
[TBL] [Abstract][Full Text] [Related]
16. IDO-independent suppression of T cell effector function by IFN-γ-licensed human mesenchymal stromal cells.
Chinnadurai R; Copland IB; Patel SR; Galipeau J
J Immunol; 2014 Feb; 192(4):1491-501. PubMed ID: 24403533
[TBL] [Abstract][Full Text] [Related]
17. T cells from autoimmune patients display reduced sensitivity to immunoregulation by mesenchymal stem cells: role of IL-2.
Ben-Ami E; Miller A; Berrih-Aknin S
Autoimmun Rev; 2014 Feb; 13(2):187-96. PubMed ID: 24121085
[TBL] [Abstract][Full Text] [Related]
18. Human bone marrow mesenchymal stem cells and chondrocytes promote and/or suppress the in vitro proliferation of lymphocytes stimulated by interleukins 2, 7 and 15.
Bocelli-Tyndall C; Bracci L; Schaeren S; Feder-Mengus C; Barbero A; Tyndall A; Spagnoli GC
Ann Rheum Dis; 2009 Aug; 68(8):1352-9. PubMed ID: 18647856
[TBL] [Abstract][Full Text] [Related]
19. Placenta-Derived Mesenchymal Stem Cells Reduce the Interleukin-5 Level Experimentally in Children with Asthma.
Lin SC; Liou YM; Ling TY; Chuang YH; Chiang BL
Int J Med Sci; 2019; 16(11):1430-1438. PubMed ID: 31673233
[No Abstract] [Full Text] [Related]
20. Interactions of human mesenchymal stromal cells with peripheral blood mononuclear cells in a Mitogenic proliferation assay.
Herzig MC; Christy BA; Montgomery RK; Delavan CP; Jensen KJ; Lovelace SE; Cantu C; Salgado CL; Cap AP; Bynum JA
J Immunol Methods; 2021 May; 492():113000. PubMed ID: 33609532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
